Noted Litigation Firm Cunningham Bounds Investigates Elmiron® Eye Damage Claims

Based in Alabama, civil litigation firm Cunningham Bounds is recognized nationwide for securing billions on behalf of injury victims. The firm is currently investigating eye damage cases linked to the use of Elmiron®, a bladder drug produced by Janssen Pharmaceuticals.

News provided by

Cunningham Bounds, LLC

Jul 07, 2020, 12:17 ET

MOBILE, Ala., July 7, 2020 /PRNewswire/ -- The law firm of Cunningham Bounds would like to announce that it is actively investigating claims about eye damage linked to Elmiron®, which is primarily composed of pentotan polysulfate sodium (PPS). With a nationwide reputation for winning billions on behalf of injury victims, Cunningham Bounds is ready to represent eye injury victims in lawsuits against Janssen Pharmaceuticals, the manufacturer of Elmiron®.

In May 2018, a peer-reviewed clinical study in Opthalmology first suggested that there was a link between PPS exposure and "pigmentary maculopathy," a progressive eye disorder that leads to vision loss and blindness. Over the last two years, several other clinical studies have connected long-term use of Elmiron® – the only drug currently approved to treat a bladder condition called interstitial cystitis – with pigmentary maculopathy. In June 2020, Janssen Pharmaceuticals even added a warning label to Elmiron® acknowledging the risk to users.

Common side effects associated with pigmentary maculopathy:

  • Dark spots in vision field
  • Difficulty reading or adjusting to dim lighting
  • Loss of color perception
  • Persistent eye strain during reading and other activities
  • Blurred vision, particularly in the central vision field
  • Blindness

Because PPS is the only known cause of pigmentary maculopathy, this condition is often misdiagnosed as age-related macular degeneration or pattern dystrophy, making it harder for eye injury victims to get the treatment they need. If you or your loved ones have taken Elmiron® and developed vision loss or blindness, you could be entitled to pursue a lawsuit against Janssen Pharmaceuticals.

To consult with Cunningham Bounds about a potential claim, visit the firm's website at https://www.cunninghambounds.com/. Consultations are free.

SOURCE Cunningham Bounds, LLC

Related Links

https://www.cunninghambounds.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED